Eidos Therapeutics, Inc.
Related Filers (19)
- BridgeBio Pharma, Inc. (26)
- Fox Jonathan C (26)
- Turtle Cameron (15)
- Sinha Uma (12)
- Siu Christine (10)
- Satvat Ali J. (9)
- Valle Franco (9)
- AGUIAR ERIC (6)
- Shah Rajeev M. (5)
- Kumar Neil (5)
- Lis William (5)
- RA CAPITAL MANAGEMENT, L.P. (4)
- VIKING GLOBAL INVESTORS LP (3)
- Rohlen Douglas (3)
- Hooper Suzanne Sawochka (3)
- Huh Hoyoung (2)
- RA Capital Healthcare Fund LP (2)
- Kolchinsky Peter (2)
- Nasdaq Stock Market LLC (1)
- Show More ...
Financials (11)
10-Q
Thursday, 10/29/2020
Quarterly Report for period ending 2020-09-30
10-Q
Thursday, 8/6/2020
Quarterly Report for period ending 2020-06-30
10-Q
Friday, 5/8/2020
Quarterly Report for period ending 2020-03-31
10-K
Wednesday, 2/26/2020
Annual Report for period ending 2019-12-31
10-Q
Thursday, 10/31/2019
Quarterly Report for period ending 2019-09-30
10-Q
Thursday, 8/1/2019
Quarterly Report for period ending 2019-06-30
10-Q
Tuesday, 5/7/2019
Quarterly Report for period ending 2019-03-31
10-K
Monday, 4/15/2019
Annual Report for period ending 2018-12-31
NT 10-K
Monday, 4/1/2019
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2018-12-31
10-Q
Tuesday, 11/6/2018
Quarterly Report for period ending 2018-09-30
10-Q
Tuesday, 8/7/2018
Quarterly Report for period ending 2018-06-30
News (31)
8-K
Tuesday, 1/26/2021
Current report filing
8-K
Wednesday, 1/20/2021
Current report filing
8-K
Tuesday, 1/12/2021
Current report filing
8-K
Thursday, 10/29/2020
Current report filing
8-K
Wednesday, 10/7/2020
Current report filing
8-K
Monday, 10/5/2020
Current report filing
8-K
Tuesday, 9/29/2020
Current report filing
8-K
Friday, 8/7/2020
Current report filing
8-K
Thursday, 8/6/2020
Current report filing
8-K
Monday, 6/1/2020
Current report filing
8-K
Friday, 5/8/2020
Current report filing
8-K
Tuesday, 3/24/2020
Current report filing
8-K
Wednesday, 2/26/2020
Current report filing
8-K
Tuesday, 1/7/2020
Current report filing
8-K
Tuesday, 12/17/2019
Current report filing
8-K
Monday, 11/18/2019
Current report filing
8-K
Thursday, 10/31/2019
Current report filing
8-K
Friday, 9/13/2019
Current report filing
8-K
Wednesday, 9/11/2019
Current report filing
8-K
Monday, 8/12/2019
Current report filing
8-K
Thursday, 8/1/2019
Current report filing
8-K
Monday, 6/17/2019
Current report filing
8-K
Tuesday, 5/7/2019
Current report filing
8-K
Monday, 4/15/2019
Current report filing
8-K
Monday, 4/1/2019
Current report filing
8-K
Wednesday, 2/27/2019
Current report filing
8-K
Thursday, 2/21/2019
Current report filing
8-K
Thursday, 12/6/2018
Current report filing
8-K
Tuesday, 11/13/2018
Current report filing
8-K
Tuesday, 11/6/2018
Current report filing
8-K
Tuesday, 8/7/2018
Current report filing
Other (21)
15-12B
Friday, 2/5/2021
Notice of termination of registration of a class of securities under Section 12(b)
EFFECT
Wednesday, 1/27/2021
Notice of Effectiveness
25-NSE
Tuesday, 1/26/2021
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
POS AM
Tuesday, 1/26/2021
Post-effective amendment to a registration statement that is not immediately effective upon filing
CORRESP
Wednesday, 7/1/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Friday, 2/28/2020
None
SEC STAFF LETTER
Monday, 2/3/2020
None
EFFECT
Thursday, 8/29/2019
Notice of Effectiveness
CORRESP
Tuesday, 8/27/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 8/23/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Tuesday, 6/19/2018
Order Granting Confidential Treatment
EFFECT
Tuesday, 6/19/2018
Notice of Effectiveness
CERT
Monday, 6/18/2018
Certification by an exchange approving securities for listing
8-A12B
Friday, 6/15/2018
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Friday, 6/15/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 6/15/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 6/15/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 6/8/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 6/5/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 5/25/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Thursday, 4/12/2018
Exempt (Private) Offering
Ownership (139)
4
Thursday, 1/28/2021
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Satvat Ali J.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Rohlen Douglas: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Hooper Suzanne Sawochka: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Lis William: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Valle Franco: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 1/26/2021
BridgeBio Pharma, Inc.: Major Shareholders
SC 13D/A
Tuesday, 1/26/2021
BridgeBio Pharma, Inc.: Major Shareholders
4
Friday, 1/15/2021
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/13/2021
Valle Franco: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/16/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/10/2020
Valle Franco: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/3/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Friday, 10/30/2020
Sinha Uma: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 10/15/2020
BridgeBio Pharma, Inc.: Major Shareholders
4
Friday, 10/9/2020
Valle Franco: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 10/7/2020
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13D/A
Monday, 10/5/2020
BridgeBio Pharma, Inc.: Major Shareholders
4
Friday, 10/2/2020
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Friday, 9/18/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/16/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 9/11/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Monday, 8/10/2020
Hooper Suzanne Sawochka: Statement of changes in beneficial ownership of securities
3
Monday, 8/10/2020
Rohlen Douglas: Initial statement of beneficial ownership of securities
4
Monday, 8/10/2020
Rohlen Douglas: Statement of changes in beneficial ownership of securities
3
Monday, 8/10/2020
Hooper Suzanne Sawochka: Initial statement of beneficial ownership of securities
4
Wednesday, 8/5/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Thursday, 7/9/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Valle Franco: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Monday, 6/1/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 5/29/2020
Lis William: Statement of changes in beneficial ownership of securities
4
Friday, 5/29/2020
Satvat Ali J.: Statement of changes in beneficial ownership of securities
4
Friday, 5/29/2020
AGUIAR ERIC: Statement of changes in beneficial ownership of securities
4
Friday, 5/29/2020
Shah Rajeev M.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/28/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/5/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Monday, 4/27/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/22/2020
Valle Franco: Statement of changes in beneficial ownership of securities
4
Monday, 3/30/2020
Valle Franco: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/4/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/4/2020
Valle Franco: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/19/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/11/2020
VIKING GLOBAL INVESTORS LP: Major Shareholders
4
Wednesday, 2/5/2020
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Thursday, 1/16/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Thursday, 1/9/2020
Fox Jonathan C: Statement of changes in beneficial ownership of securities
3
Thursday, 1/9/2020
Valle Franco: Initial statement of beneficial ownership of securities
4
Friday, 12/20/2019
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/11/2019
Siu Christine: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/10/2019
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Thursday, 12/5/2019
Siu Christine: Statement of changes in beneficial ownership of securities
4
Thursday, 12/5/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/27/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 11/22/2019
Siu Christine: Statement of changes in beneficial ownership of securities
4
Friday, 11/22/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 11/22/2019
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/19/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/16/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 10/15/2019
BridgeBio Pharma, Inc.: Major Shareholders
4
Friday, 9/27/2019
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/18/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 9/6/2019
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Monday, 8/19/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 8/8/2019
BridgeBio Pharma, Inc.: Major Shareholders
4
Monday, 7/29/2019
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/17/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 7/12/2019
Siu Christine: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 7/9/2019
BridgeBio Pharma, Inc.: Major Shareholders
4
Monday, 7/8/2019
Kumar Neil: Statement of changes in beneficial ownership of securities
4
Monday, 7/8/2019
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/8/2019
Satvat Ali J.: Statement of changes in beneficial ownership of securities
4
Monday, 7/8/2019
AGUIAR ERIC: Statement of changes in beneficial ownership of securities
4
Friday, 6/28/2019
Siu Christine: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
AGUIAR ERIC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
Lis William: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
Shah Rajeev M.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
Satvat Ali J.: Statement of changes in beneficial ownership of securities
4
Friday, 6/7/2019
Siu Christine: Statement of changes in beneficial ownership of securities
4
Thursday, 6/6/2019
Turtle Cameron: Statement of changes in beneficial ownership of securities
4
Friday, 5/31/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 5/30/2019
BridgeBio Pharma, Inc.: Major Shareholders
4
Wednesday, 5/29/2019
Kumar Neil: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
Satvat Ali J.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
AGUIAR ERIC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/28/2019
Sinha Uma: Statement of changes in beneficial ownership of securities
4
Monday, 5/6/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 5/3/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Friday, 4/26/2019
Siu Christine: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/16/2019
Fox Jonathan C: Statement of changes in beneficial ownership of securities
4
Thursday, 3/21/2019
Siu Christine: Statement of changes in beneficial ownership of securities
Prospectus (29)
S-8 POS
Tuesday, 1/26/2021
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 1/26/2021
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 1/26/2021
Post-effective amendment to a S-8 registration statement
425
Wednesday, 1/13/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 1/13/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 1/12/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 1/12/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 1/7/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 1/4/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 12/29/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 12/28/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 11/2/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 10/7/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 10/7/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 10/6/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 10/5/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 10/5/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
S-8
Tuesday, 6/9/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3/A
Friday, 8/23/2019
Registration statement for specified transactions by certain issuers
S-3
Friday, 8/2/2019
Registration statement for specified transactions by certain issuers
S-8
Friday, 8/2/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 6/21/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Thursday, 6/21/2018
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Friday, 6/15/2018
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Friday, 6/8/2018
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 5/25/2018
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Wednesday, 5/2/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 5/1/2018
Correspondence Related to Draft Registration Statement
DRS
Friday, 3/23/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (4)
DEFM14A
Tuesday, 12/15/2020
Definitive proxy statement relating to a merger, acquisition, or disposition
DEFA14A
Friday, 4/24/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 4/24/2020
Definitive proxy statements
DEF 14A
Monday, 4/29/2019
Definitive proxy statements